Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Human Genome Sciences acquires rights to anticancer drug FP-1039 from FivePrime

March 17, 2011

Epistem and sanofi-aventis enter oncology biomarker collaboration

March 17, 2011

Genfit and sanofi-aventis sign new agreement to develop drugs for metabolic disorders

March 17, 2011

Cleveland Clinic grants Apeiron option to license SHP-1 inhibitors

March 16, 2011

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

March 16, 2011

Boehringer Ingelheim obtains rights to Acuform technology and Glumetza data

March 16, 2011

Seattle Genetics and Millennium extend antibody-drug conjugate agreement

March 16, 2011

Meiji Seika and RaQualia enter into license agreement for ziprasidone in Japan

March 15, 2011

ChronTech initiates phase IIb trial of its HCV DNA vaccine with Inovio's MedPulser delivery device

March 15, 2011

Collaboration established for research into beta-cell regeneration in diabetes

March 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...